2 Recession-Proof Stocks to Watch in December

Motley Fool identifies Walmart and Johnson & Johnson as recession‑resistant, income‑oriented names: Walmart’s low‑price, broad‑assortment, nationwide store footprint tends to capture budget‑conscious shoppers in downturns, while J&J’s diversified pharmaceuticals and medical‑device franchises (after spinning off consumer health in August 2023) benefit from non‑cyclical healthcare demand. Both are Dividend Kings with long streaks of annual increases (Walmart 52 years, J&J 63 years) and have shown historical resilience in the Great Recession (WMT rose ~4% vs. the S&P 500’s ~38% decline, JNJ finished about +47% from Dec 2007–Jun 2009). Nonetheless, Motley Fool’s Stock Advisor did not include Walmart in its current top‑10 buy list, indicating its analysts favor other opportunities despite these defensive attributes.

Analysis

Motley Fool highlights Walmart and Johnson & Johnson as recession‑resistant holdings: Walmart’s low‑price, broad‑assortment, nationwide retail footprint tends to capture budget‑conscious shoppers, while Johnson & Johnson’s diversified pharmaceuticals and medical‑device franchises—following the consumer‑health spinoff in August 2023—benefit from non‑cyclical healthcare demand. Both are Dividend Kings, with Walmart having increased its dividend for 52 consecutive years and Johnson & Johnson for 63 years, providing an income cushion during downturns.

The article cites historical resilience: Walmart’s stock rose nearly 4% during the Great Recession (Dec 2007–Jun 2009) versus an S&P 500 decline of ~38%, and Johnson & Johnson finished that period up over 47%. It also notes J&J has lagged the S&P over the past decade, and that Motley Fool’s Stock Advisor did not include Walmart in its current top‑10 buys, implying potential opportunity cost versus higher‑growth recommendations.

Sentiment on these names is moderately positive with low market‑impact, supporting a defensive allocation thesis rather than signaling an imminent re‑rating. Investors should view WMT and JNJ as reliable dividend anchors and recession hedges but weigh slower relative growth and the Stock Advisor omission when determining position size.

Key Decisions for Investors

• Consider a modest allocation to Walmart and Johnson & Johnson as defensive, dividend-generating holdings to hedge a potential 2026 downturn given Walmart’s value-retail positioning and J&J’s non-cyclical franchises
• Size Walmart exposure conservatively and benchmark it against the Stock Advisor top-10 alternatives because the report explicitly omitted WMT, indicating potential opportunity cost versus higher-return ideas
• Prefer J&J for core income and non-cyclical exposure but monitor its post-spin-off dynamics (consumer-health spinoff August 2023) and its decade-long lag versus the S&P before increasing exposure
• Monitor consumer shifts toward discount retail and the resilience of healthcare demand as the primary indicators to trigger rebalancing of defensive positions